Andrea Baldini։ Aspirin Prophylaxis Is Effective But Still Off-Label In Some Countries
Andrea Baldini, Instute Director at IFCA Clinic, shared The Bone and Joint Journal’s post on LinkedIn, adding:
”More and more high level evidence for an established prophylaxis which in my country is still considered ‘off label’…”
The Bone and Joint Journal, shared a post on LinkedIn about a recent article by Billy I. Kim, adding:
”The risk of thromboembolic events must be weighed against the increased potential for bleeding with more potent anticoagulants.”
Title: Aspirin prophylaxis is safe and effective for venous thromboembolism prophylaxis in low-risk patients undergoing aseptic revision total knee arthroplasty
Authors: Billy I. Kim, Brian P. Chalmers, Fred D. Cushner, Peter K. Sculco
Stay updated on all scientific advances with Hemostasis Today.
-
May 15, 2026, 17:22Smbat Marukyan: How Inflamed Gums Can Lead to a Heart Attack – The Chain of Events
-
May 15, 2026, 17:20Ayman Arif: Understanding PRP Therapy in Aesthetic Medicine
-
May 15, 2026, 17:17Daniel Soffer: 2026 Dyslipidemia Guideline Pre-Proof Now Available Online
-
May 15, 2026, 17:14Alastair Lewis: Another The British Association of Sclerotherapists Annual Meeting Has Concluded
-
May 15, 2026, 17:12Uniting Global Partners to Transform Stroke Advocacy and Policy – International Journal of Stroke
-
May 15, 2026, 17:02Alyssa George: Anticoagulation Management During the Diagnostic Evaluation of HIT
-
May 15, 2026, 16:53Judeline Casimir: Preeclampsia Awareness Month – Moving From Knowing the Risks to Saving Lives
-
May 15, 2026, 16:51Muhammad Hashim Ali: A Clear Overview of Anemia and Its Mechanisms
-
May 15, 2026, 16:43Joseph R. Shaw: Thrombin Generation as a Pharmacodynamic Framework for Anticoagulant Therapy